Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N9CV
|
|||
Drug Name |
PMID25482888-Compound-11
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H26N6O
|
|||
Canonical SMILES |
C1CC(N(C1)C(=O)CNC23CC4CC2CC(C4)(C3)CN5C=NC=N5)C#N
|
|||
InChI |
1S/C19H26N6O/c20-8-16-2-1-3-25(16)17(26)9-22-19-6-14-4-15(19)7-18(5-14,10-19)11-24-13-21-12-23-24/h12-16,22H,1-7,9-11H2/t14?,15?,16-,18?,19?/m0/s1
|
|||
InChIKey |
IGRDXWYZILJAIK-YYSDWXCKSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dipeptidyl peptidase 4 (DPP-4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dipeptidyl peptidase 4 (DPP-4) | Target's Patent Info | [1] | |
KEGG Pathway | Protein digestion and absorption | |||
NetPath Pathway | IL2 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | DPP-4 inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Feb;25(2):209-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.